China CRO Company,Preclinical research services

encnjpkr

News

Press Events

Location:Home > News Center > Press Events

  • 07
    27

    2015

    3SBio Acquires Zhejiang Wansheng Pharmaceutical for $85M

    3SBio said it has acquired Zhejiang Wansheng Pharmaceutical for RMB 528 million ($85 million), less than a month after completing the largest IPO of the first half of 2015.

  • 07
    27

    2015

    Biopharms Up Spending by $300 Million on Bioprocess Innovations

    Innovation to improve bioprocessing efficiency is in high demand and the global biopharma industry is increasing their development spending by $300 million in 2015, according to the 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production from BioPlan Associates.

  • 07
    24

    2015

    Flu Vaccine Becomes Universal

    While many of us are spending the last half of the summer deciding where the nicest beaches are and who makes the best island cocktails, infectious disease scientists are looking ahead toward the next inevitable outbreak of the flu.  Influenza hunters travel to hot zones that have long been the traditional breeding grounds and launching points for global seasonal pandemics. This is an important part of creating seasonal flu vaccines, which protect against only a few specific strains that researchers predict will be the most common for the upcoming year.

  • 07
    24

    2015

    New Molecular Inhibitor Stimulates Tissue Regeneration

    The ability to create agents that promote tissue regeneration would have overwhelmingly beneficial implications within the clinical setting. Now, a collaboration of researchers from UT Southwestern Medical Center, Case Western Reserve University, and the University of Kentucky has identified an enzyme they say regulates tissue regeneration. The scientists believe that the inhibition of this enzyme could accelerate tissue recovery from injury, disease, or even various surgical procedures in multiple organ systems.

  • 07
    23

    2015

    New Hope for ALS Sufferers

    Researchers at the CHUM Research Center and the University of Montreal report the discovery of a previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The scientists believe their research paves the way to an entirely new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's, and Huntington's diseases.